JP2025069304A5 - - Google Patents
Info
- Publication number
- JP2025069304A5 JP2025069304A5 JP2025015275A JP2025015275A JP2025069304A5 JP 2025069304 A5 JP2025069304 A5 JP 2025069304A5 JP 2025015275 A JP2025015275 A JP 2025015275A JP 2025015275 A JP2025015275 A JP 2025015275A JP 2025069304 A5 JP2025069304 A5 JP 2025069304A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- pharmaceutically acceptable
- acceptable salt
- chain fatty
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762451192P | 2017-01-27 | 2017-01-27 | |
| US62/451,192 | 2017-01-27 | ||
| US201762510867P | 2017-05-25 | 2017-05-25 | |
| US201762510872P | 2017-05-25 | 2017-05-25 | |
| US62/510,867 | 2017-05-25 | ||
| US62/510,872 | 2017-05-25 | ||
| US201762530371P | 2017-07-10 | 2017-07-10 | |
| US62/530,371 | 2017-07-10 | ||
| US201762539572P | 2017-08-01 | 2017-08-01 | |
| US62/539,572 | 2017-08-01 | ||
| US201762588961P | 2017-11-21 | 2017-11-21 | |
| US62/588,961 | 2017-11-21 | ||
| PCT/US2018/015383 WO2018140687A1 (en) | 2017-01-27 | 2018-01-26 | Use of short chain fatty acids for the treatment and prevention of diseases and disorders |
| JP2019562212A JP7161731B2 (ja) | 2017-01-27 | 2018-01-26 | 疾患及び障害の処置及び予防のための短鎖脂肪酸の使用 |
| JP2022161035A JP7688360B2 (ja) | 2017-01-27 | 2022-10-05 | 疾患及び障害の処置及び予防のための短鎖脂肪酸の使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022161035A Division JP7688360B2 (ja) | 2017-01-27 | 2022-10-05 | 疾患及び障害の処置及び予防のための短鎖脂肪酸の使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025069304A JP2025069304A (ja) | 2025-04-30 |
| JP2025069304A5 true JP2025069304A5 (https=) | 2026-01-08 |
Family
ID=62978768
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019562212A Active JP7161731B2 (ja) | 2017-01-27 | 2018-01-26 | 疾患及び障害の処置及び予防のための短鎖脂肪酸の使用 |
| JP2022161035A Active JP7688360B2 (ja) | 2017-01-27 | 2022-10-05 | 疾患及び障害の処置及び予防のための短鎖脂肪酸の使用 |
| JP2025015275A Pending JP2025069304A (ja) | 2017-01-27 | 2025-01-31 | 疾患及び障害の処置及び予防のための短鎖脂肪酸の使用 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019562212A Active JP7161731B2 (ja) | 2017-01-27 | 2018-01-26 | 疾患及び障害の処置及び予防のための短鎖脂肪酸の使用 |
| JP2022161035A Active JP7688360B2 (ja) | 2017-01-27 | 2022-10-05 | 疾患及び障害の処置及び予防のための短鎖脂肪酸の使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US20220142978A1 (https=) |
| JP (3) | JP7161731B2 (https=) |
| KR (1) | KR102646764B1 (https=) |
| CN (1) | CN110475551A (https=) |
| WO (1) | WO2018140687A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10588871B1 (en) | 2019-06-28 | 2020-03-17 | Nexzol Pharma, Inc. | Transdermal formulation for the treatment of pain and/or inflammation |
| CN116322773A (zh) * | 2020-04-21 | 2023-06-23 | 马萨诸塞大学 | 用于治疗年龄相关性黄斑变性的方法和组合物 |
| FR3111551B1 (fr) * | 2020-06-19 | 2022-08-26 | Oreal | Composition gélifiée comprenant un sel d’acide gras à chaîne courte |
| CN111632047A (zh) * | 2020-07-27 | 2020-09-08 | 上海市中医医院 | 木犀草素在预防和治疗子宫内膜异位症药物中的应用 |
| US20240009154A1 (en) * | 2020-08-04 | 2024-01-11 | Temple University-Of The Commonwealth System Of Higher Education | Methods and compositions for treating cytokine release syndrome |
| AU2021380836A1 (en) * | 2020-11-12 | 2023-06-22 | Alla ARZUMANYAN | Use of short chain fatty acids in cancer prevention |
| EP4333860A4 (en) * | 2021-05-07 | 2025-06-04 | Board of Regents, The University of Texas System | SERUM METABOLOMICS RELATED TO CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY |
| CN114767685B (zh) * | 2022-04-25 | 2023-10-20 | 北京大学第三医院（北京大学第三临床医学院） | 四氢叶酸在抑菌或者预防或治疗眼部疾病中的用途 |
| GB202208911D0 (en) * | 2022-06-17 | 2022-08-10 | Ravan Bio Limtied | Treatments |
| CN115068457A (zh) * | 2022-07-04 | 2022-09-20 | 南昌大学第一附属医院 | 短链脂肪酸在制备治疗急性胰腺炎药物中的应用 |
| JP7401156B1 (ja) | 2022-11-08 | 2023-12-19 | ミヤリサン製薬株式会社 | 子宮、卵管および卵巣における炎症の予防および／または治療剤 |
| FR3141616A1 (fr) * | 2022-11-09 | 2024-05-10 | Pll Therapeutics | Principes actifs et leur utilisation pour rétablir la perméabilité intestinale et/ou prévenir ou lutter contre des maladies multifactorielles |
| AU2023375510A1 (en) * | 2022-11-10 | 2025-05-29 | Temple University-Of The Commonwealth System Of Higher Education | Methods of treating or preventing liver diseases or disorders |
| JP2026504052A (ja) * | 2023-01-11 | 2026-02-03 | テンプル・ユニバーシティ－オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション | 短鎖脂肪酸による皮膚障害の処置 |
| CN116687899B (zh) * | 2023-07-10 | 2025-03-21 | 河北医科大学第二医院 | 短链脂肪酸钠盐丁酸钠和丙酸钠组合用药在als治疗中的应用 |
| US12102611B2 (en) * | 2024-03-25 | 2024-10-01 | Olfactive Biosolutions, LLC | Compositions and methods for treating hypertension by modulating endocrine activity |
| US12226383B1 (en) * | 2024-04-30 | 2025-02-18 | Velocity Life Sciences, LLC | Compositions containing short-chain fatty acid, methods of use, and methods of making thereof |
| CN120093748B (zh) * | 2025-03-26 | 2026-02-06 | 江汉大学 | 包含异戊酸和仑伐替尼的组合物在制备抗癌药物中的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4735967A (en) * | 1985-05-28 | 1988-04-05 | Neesby Torben E | Method for desensitizing the gastrointestinal tract from food allergies |
| JP2000072667A (ja) | 1998-08-25 | 2000-03-07 | Kurasuraa:Kk | 大腸炎治療用経口投与剤 |
| US8846039B2 (en) * | 2002-04-26 | 2014-09-30 | Asan Laboratories Company (Cayman), Limited | Method for ameliorating pruritus |
| US20080153908A1 (en) * | 2006-12-20 | 2008-06-26 | Jani Dharmendra M | Method of Treating Mucin Deficiency with an Active Pharmaceutical and Related Composition |
| WO2009087474A2 (en) | 2008-01-08 | 2009-07-16 | Akthelia Pharmaceuticals | Agonists for antimicrobial peptide systems |
| US9339667B2 (en) * | 2009-02-18 | 2016-05-17 | Sea Qiq As | Mixture of inorganic compounds, preparations containing the mixture and use of the mixture |
| US8962686B2 (en) | 2010-04-28 | 2015-02-24 | The Chinese University Of Hong Kong | Method and medication for prevention and treatment of ocular hypertension and glaucoma |
| EP2389932A1 (en) * | 2010-05-28 | 2011-11-30 | Lunamed AG | Compositions for use in genetic disorders comprising 4-phenyl-butyric acid and its salts |
| WO2012013495A1 (en) * | 2010-07-29 | 2012-02-02 | Cosmo Technologies Ltd. | Pharmaceutical and/or dietary compositions based on short chain fatty acids |
| WO2012131069A1 (en) * | 2011-03-31 | 2012-10-04 | Proponent Biotech Gmbh | Short chain fatty acids and their derivatives for use in treatment immunogenic disorders |
| WO2014022886A1 (en) * | 2012-08-08 | 2014-02-13 | Fischer Karen Jane | A method, use, and dietary supplement composition for at least treating an atopic or non-atopic disorder in a patient |
| WO2015006355A2 (en) * | 2013-07-09 | 2015-01-15 | Puretech Ventures, Llc | Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease |
| US10092541B2 (en) * | 2014-08-15 | 2018-10-09 | Celgene Corporation | Methods for the treatment of diseases ameliorated by PDE4 inhibition using dosage titration of apremilast |
-
2018
- 2018-01-26 KR KR1020197024459A patent/KR102646764B1/ko active Active
- 2018-01-26 JP JP2019562212A patent/JP7161731B2/ja active Active
- 2018-01-26 CN CN201880021752.2A patent/CN110475551A/zh active Pending
- 2018-01-26 WO PCT/US2018/015383 patent/WO2018140687A1/en not_active Ceased
-
2022
- 2022-01-25 US US17/584,125 patent/US20220142978A1/en active Pending
- 2022-10-05 JP JP2022161035A patent/JP7688360B2/ja active Active
-
2024
- 2024-09-30 US US18/901,917 patent/US20250017883A1/en active Pending
- 2024-12-10 US US18/975,545 patent/US20250099410A1/en active Pending
-
2025
- 2025-01-31 JP JP2025015275A patent/JP2025069304A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025069304A5 (https=) | ||
| JP2022191257A5 (https=) | ||
| JP4415243B2 (ja) | 脂肪酸の治療効果の増強作用 | |
| ES2214729T3 (es) | Acido 9-cis-retinoico para enfermedades inmunes inducidas por celulas. | |
| EP0085579B1 (en) | Topical pharmaceutical compositions | |
| JP2019048843A5 (https=) | ||
| JP2023002662A5 (https=) | ||
| TW200417368A (en) | Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection | |
| JP2025092508A5 (https=) | ||
| CA2656858A1 (en) | Positively charged water-soluble prodrugs of acetylsalicylic acid | |
| US20060004076A1 (en) | Co-administration of dehydroepiandrosterone (DHEA) congener with pharmaceutically active agents for treating inflammation | |
| JP2014507476A (ja) | 高尿酸血症および高尿酸血症関連代謝障害を治療するための方法および組成物 | |
| WO2002085327A2 (en) | Use of nsaids for prevention and treatment of cellular abnormalities of the female reproductive tract | |
| IL294736A (en) | Preparations including 15-hydroxy-eicosapentaenoic acid and methods of using them | |
| JP2024542943A5 (https=) | ||
| PH12021553056A1 (en) | Modified release formulations and uses thereof | |
| JP2005513014A5 (https=) | ||
| JP2024069223A5 (https=) | ||
| WO2024088153A1 (zh) | 托品酸及其衍生物在制备治疗银屑病药物中的用途 | |
| JP2017533956A (ja) | 筋肉痛を含む病態の治療のための組合せ | |
| JP2024540439A5 (https=) | ||
| RU2005122466A (ru) | Фармацевтические композиции, включающие комбинацию кальцитриола и клобетазола пропионат | |
| JP2023531930A5 (https=) | ||
| JP4890250B2 (ja) | 火傷した皮膚を治療するための方法及び組成物 | |
| JP2025522146A5 (https=) |